DOCSLIB.ORG

Pharmaceutical Company Contact Information (PDF)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pharmaceutical Company Contact Information (PDF) Pharmaceutical Company Contact Information - Rebate Filing - as of June 2018 Labeler Name Invoice Contact Phone Extension 00002 LILLY USA, LLC LISA NORTON (317) 276-2000 00003 ER SQUIBB AND SONS INC. LYNN LEWIS (609) 897-4731 00004 GENENTECH CONTRACT ADMINISTRATION (650) 866-2666 00005 LEDERLE LABORATORIES DAN MAGUIRE (484) 563-5097 00006 MERCK & CO., INC. DOUG BICKFORD (215) 652-0671 00007 SMITHKLINE BEECHAM DAVID BUCKLEY (215) 751-5690 00008 WYETH LABORATORIES JENNIFER WOOTEN (901) 215-1883 00009 PHARMACIA AND UPJOHN COMPANY/PFIZER JENNIFER WOOTEN (901) 215-1883 00013 PHARMACIA AND UPJOHN COMPANY NICHOLAS CHRISTODOULOU (336) 291-1053 00014 G. D. SEARLE & CO. CINDY MCDONALD (847) 581-5726 00015 MEAD JOHNSON AND COMPANY LYNN LEWIS (609) 897-4731 00016 PHARMACIA INC. BARBARA WINGET (908) 901-7254 00023 ALLERGAN INC SHOBHANA MINAWALA (714) 246-6205 00024 SANOFI WINTHROP PHARMACEUTICALS LAURIE DUNLAP, ADMIN., GOVT. OPERATIONS (212) 551-4198 00025 PHARMACIA CORPORATION NICHOLAS CHRISTODOULOU (336) 291-1053 00026 BAYER CORPORATION PHARMACEUTICAL DIV. LINDA WOLCHESKI (203) 812-6372 00028 NOVARTIS PHARMACEUTICALS (862) 778-8094 00029 SMITHKLINE BEECHAM DAVID BUCKLEY (215) 751-5690 00031 A. H. ROBINS COMPANY DAN MAGUIRE (610) 902-3222 00032 SOLVAY PHARMACEUTICALS STACEY LENOX (847) 937-3979 00033 SYNTEX LABORATORIES, INC. JANICE BRENNAN (973) 562-3494 00034 THE PURDUE FREDERICK COMPANY JUNE STOWE (203) 899-8035 00037 CARTER-WALLACE, INC. JAY R BRENNAN (609) 655-6163 00038 ASTRAZENECA LP DAVID WRIGHT (302) 886-2268 7820 00039 AVENTIS PHARMACEUTICALS (908) 981-7461 00043 NOVARTIS CONSUMER HEALTH, INC. EDWARD D. COLLINS (973) 781-6191 00044 KNOLL LABORATORIES DEBRA DEYOUNG (847) 937-4372 00045 MCNEIL PHARMACEUTICAL (908) 218-6777 00046 AYERST LABORATORIES (901) 215-1473 00047 WARNER CHILCOTT LABORATORIES LISA KAROLCHYK (973) 442-3262 00048 KNOLL PHARMACEUTICAL COMPANY DEBRA DEYOUNG (847) 937-4372 00049 ROERIG NICHOLAS CHRISTODOULOU (336) 291-1053 00051 UNIMED PHARMACEUTICALS, INC STACY LENOX (847) 937-3979 00052 ORGANON, USA, INC. (973) 325-4500 Page 1 of 22 00053 AVENTIS PHAMACEUTICALS JOE DELPONTE (908) 243-7770 00054 ROXANE LABORATORIES, INC. VICKY ARIAS (615) 431-0793 00056 DUPONT PHARMACEUTICALS ALANNA GURWITZ (302) 892-1134 00058 NOVARTIS OPHTHALMICS BONNIE SHARKEY (862) 778-8094 00060 DUPONT PHARMACEUTICALS THERESA M. DELUCA (302) 992-2104 00062 ORTHO PHARMACEUTICAL CORPORATION (908) 218-6466 00064 HEALTHPOINT, LTD. PAM BENNETT (817) 900-4000 4074 00065 ALCON LABORATORIES, INC. DEBBIE NIXON, MNGR GOV'T PRICING & REBA (817) 568-6231 00066 AVENTIS PHARMACEUTICALS MATTHEW MUELLER (908) 981-7461 00067 NOVARTIS CONSUMER HEALTH, INC. (973) 781-6101 00068 AVENTIS PHARMACEUTICALS JOE DELPONTE (908) 243-7770 00069 PFIZER LABORATORIES DIV OF PFIZER INC JENNIFER WOOTEN (901) 215-1883 00070 AVENTIS PHARMACEUTICALS JOE DELPONTE (908) 243-7770 00071 PARKE-DAVIS DIV OF PFIZER, INC. JENNIFER WOOTEN (901) 215-1883 00072 WESTWOOD SQUIBB PHARMACEUTICALS CARLOS TORRUELLAS (609) 897-4731 00074 ABBVIE US LLC AMANDA TUCKER (847) 938-8970 00075 AVENTIS PHARMACEUTICALS JOE DELPONTE (908) 243-7770 00076 STAR PHARMACEUTICALS INC. RUTH M. THOMAS (954) 971-9704 00078 NOVARTIS PHARMACEUTICALS CORPORATION BONNIE SHARKEY (862) 778-8094 00081 BURROUGHS WELLCOME CO TAYLOR HOLT (919) 483-2115 00083 NOVARTIS PHARMACEUTICALS BONNIE SHARKEY (862) 778-8094 00085 MERCK SHARP & DOHME CORP. ELAINE CARTER (908) 653-2851 00086 CARNRICK LABORATORIES INC MARIE STANLEY (973) 267-2670 00087 BRISTOL-MYERS SQUIBB COMPANY ALANNA GURWITZ (609) 897-4758 00088 AVENTIS PHARMACEUTICALS JOE DELPONTE (908) 243-7770 00089 GRACEWAY PHARMACETICALS (267) 948-0430 00091 SCHWARZ PHARMA KREMERS URBAN COMPANY LAKESHA INGRAM (770) 970-8229 00093 LEMMON COMPANY LISA PEPE (215) 591-8567 5320 00094 DUPONT PHARMACEUTICALS THERESA M. DELUCA (302) 992-2104 00095 WILLIAM P. POYTHRESS COMPANY DAVIS S. CASKEY (804) 527-1950 00108 SMITHKLINE BEECHAM BRENDA STALLINGS (215) 751-5690 00113 L. PERRIGO COMPANY REBECCA STRATTON (616) 673-7943 00115 GLOBAL PHARMACEUTICAL CORPORATION (215) 558-4349 00116 XTTRIUM LABORATORIES, INC. (773) 268-5800 00118 BAYER CORPORATION ALLERGY PRODUCTS RHONDA NEWTON (203) 812-6372 00121 PHARMACEUTICAL ASSOCIATES, INC. JANICE THOMAS (813) 839-6565 11 00126 COLGATE ORAL PHARMACEUTICALS SUSAN J. DIGIROLAMO (781) 821-2880 2421 Page 2 of 22 00131 SCHWARZ PHARMA MANUFACTURING LAKESHA INGRAM (770) 970-8229 00132 C B FLEET COMPANY INC CINDY HICKS (804) 528-4000 218 00135 SMITHKLINE BEECHAM BRENDA STALLINGS (215) 751-5690 00140 ROCHE LABORATORIES ADRIANNA ARANDA (650) 225-6735 00143 WEST-WARD PHARMACEUTICAL CORP SILVANA SANTIAGO (732) 542-1191 00144 SUPERIOR PHARMACEUTICAL COMPANY KAREN OCONNER (513) 851-3600 3044 00145 STIEFEL LABORATORIES INC (305) 443-3800 00147 CAMALL COMPANY SID SCHMALL (810) 752-9683 00149 WARNER CHILCOTT (US), LLC KINNA PATEL (714) 246-5365 00152 THE GRAY PHARMACEUTICAL COMPANY JUNE R. MACK (203) 854-7068 00161 BAYER CORPORATION BIOLOGICAL PRODUCTS RHONDA NEWTON (203) 812-6372 00165 BLAINE COMPANY, INC. GLENN SCHMITT (606) 283-9437 00168 E FOUGERA AND CO, DIV OF ALTANA INC (631) 719-3051 00169 NOVO NORDISK PHARMACEUTICALS INC. CORISSA PREVETE (609) 987-3930 00172 ZENITH LABORATORIES, INC LISSA PEPE (305) 575-4186 00173 GLAXO WELLCOME INC. DAVID BUCKLEY (919) 483-7942 00178 MISSION PHARMACAL COMPANY AMY CERVERA (210) 696-8400 00182 GOLDLINE LABORATORIES INC LISA PEPE (305) 575-4222 00185 EON LABS MANUFACTURING, INC. (862) 778-0274 00186 ASTRAZENECA LP DAVID WRIGHT (302) 886-7598 00187 VALEANT PHARMACEUTICALS INTERNATIONAL RANDALL PERRY (714) 545-0100 3391 00192 BAYER CORPORATION BIOLOGICAL PRODUCTS RHONDA NEWTON (203) 812-6372 00205 LEDERLE PARENTERALS DAN MAGUIRE (610) 902-3222 00206 LEDERLE PIPERACILLIN DAN MAGUIRE (610) 902-3222 00209 MARSAM PHARMACEUTICALS INC. MICHELE SOLIMO, SUPERVISOR (973) 355-8414 00217 DUNHALL PHARMACEUTICALS FAYE BOHALL (501) 787-5232 00224 KONSYL PHARMACEUTICALS, INC. ARLENE GRADY (817) 763-8011 11 00225 B F ASHER COMPANY INC., RONALD L. SANDSTROM (913) 888-1880 00228 ACTAVIS ELIZABETH LLC JUDITH RIVANO (973) 658-1808 00245 UPSHER-SMITH LABORATORIES INC., (262) 476-5063 00254 VINTAGE PHARMACEUTICALS, INC. CHARLES V. PROPST (205) 859-4011 00256 FLEMING AND COMPANY RALPH SIMPSON (314) 343-8200 00258 INWOOD LABORATORIES INC KINNA PATEL (714) 246-5365 00259 MERZ PHARMACEUTICALS KATHY JARRETT (910) 856-2003 335 00263 RYSTAN COMPANY, INC. SUSAN CONKLIN (973) 256-3737 00264 B. BRAUN MEDICAL INC. RANDY CLARK (949) 660-2389 00268 CENTER LABORATORIES JEREMY MASSETT (707) 224-3200 385 Page 3 of 22 00274 SCHERER LABORATORIES INC JOHN GIRARDI (972) 612-6225 00277 LASER INC JOSEPH N ALLEGRETTI (219) 663-1165 00281 SAVAGE LABORATORIES, DIV OF ALTANA INC DANIEL WOOD (631) 719-3051 00288 FLUORITAB CORPORATION LANICE ANDRES (734) 847-3985 00299 GALDERMA LABORATORIES, INC. SHANELLE LEACH (919) 714-6955 00300 TAP PHARMACEUTICALS INC DIANE LATZ (224) 554-1478 00303 BAUSCH & LOMB PHARMACEUTICALS, INC. DEBORAH CARPENTER (813) 866-2012 00304 J J BALAN BARRY BRODSKY (718) 251-8663 00310 ASTRAZENECA LP DAVID WRIGHT (302) 886-7598 00314 HYREX PHARMACEUTICALS MALCOLM BAKER (901) 794-9050 00327 GUARDIAN LABS DIV UNITED-GUARDIAN INC ROBERT RUBINGER (516) 273-0900 0017 00332 BIOCRAFT LABORATORIES, INC. KEN REINER, MGR., ACCNTS RECEIVABLES (215) 256-8400 5320 00338 BAXTER HEALTHCARE CORPORATION ANDREW L. THORRENS (847) 948-4646 00349 PARMED PHARMACEUTICALS INC. PAUL SANTORO (716) 284-5666 169 00353 AMERICAN PHARMACAL, INC. CHARLES ALLEN (210) 349-4922 00364 SCHEIN PHARMACEUTICAL INC MICHELE SOLIMO, SUPERVISOR (973) 355-8414 00369 SCHERING CORPORATION MANUEL ARAUJO (908) 820-4850 00372 SCOT-TUSSIN PHARMACAL CO., INC. SALVATORE G. SCOTTI, PHD, RPH, PRES. (401) 942-8555 00378 MYLAN PHARMACEUTICALS, INC. LYNN MIHALIK (800) 826-9526 00386 GEBAUER COMPANY CORRINE ADAMS (216) 271-5252 12 00392 CRANDALL ASSOCIATE JERRY SCHOLL (970) 532-4460 00402 STERIS LABORATORIES, INC. MICHELE SOLIMO, SUPERVISOR (973) 355-8414 00406 MALLINCKRODT INC. DEBBIE LEHMKOHL (314) 654-6226 00409 AP PHARMACEUTICALS, INC. DEBRA L. DEYOUNG (847) 937-6982 00414 SUPPOSITORIA LABORATORIES REBECCA STRATTON (269) 686-1838 00421 FIELDING COMPANY BILLY GEORGES (314) 567-5462 00426 MORTON GROVE PHARMACEUTICALS, INC. SUZANNE GUPTA (847) 967-5600 00430 WARNER CHILCOTT LABORATORIES (973) 442-3262 00456 FOREST PHARMACEUTICALS INC AMI SHAH (714) 246-3395 00462 PHARMADERM, DIV OF ALTANA INC DANIEL WOOD (631) 719-3051 00469 LYPHOMED DIVISION FUJISAWA USA INC. (800) 888-7704 00472 ACTAVIS MID ATLANTIC LLC JUDITH RIVANO (862) 261-7000 00482 BRADLEY PHARMACEUTICALS DANIEL WOOD (631) 719-3051 00484 SMITHKLINE BEECHAM BRENDA STALLINGS (215) 751-5690 00485 EDWARDS PHARMACEUTICALS, INC. LINDA WHITE FREEMAN (601) 837-8182 00486 BEACH PRODUCTS INC JANICE THOMAS (813) 839-6565 11 00487 NEPHRON PHARMACEUTICALS CORPORATION STEVEN F. SIMMONS (407) 246-1389 Page 4 of 22 00496 FERNDALE LABORATORIES INC. DARLEEN SEXTON (248) 548-0279 00501 WARNER-LAMBERT MONA BASS (973) 540-4639 00514 DOW HICKAM PHARMACEUTICALS INC. HAZEL DAVISON (713) 240-1000 00517 AMERICAN REGENT LABORATORIES, INC. MARY JANE HELENEK (516) 924-4000 102 00524 KNOLL PHARMACEUTICAL COMPANY DEBRA DEYOUNG (201) 428-4150 00525 PAN AMERICAN LABORATORIES INC. SAMUEL M. CAMP (504) 893-4097 00527 LANNETT COMPANY INC. CATHY STOKLOSA (215) 333-9000 00535 FOREST PHARMACEUTICALS 00536 RUGBY LABORATORIES INC MICHELE SOLIMO, SUPERVISOR (973) 355-8414 4117 00548 INTERNATIONAL MEDICATION SYSTEMS LTD CAROL CENZANO (585) 274-5948 00551 THE SEATRACE COMPANY ROBERT L. RICHARDSON,
Load more

Recommended publications
  • 2009: Turning the Corner
    data page 2009: Turning the corner Walter Yang Despite the shaky start to 2009, the biotech sector regained its financial Although initial public offerings showed signs of resuscitation (at least footing. Biotech indices were up, as were offerings and partnership mon- 13 more companies are now in the queue), follow-on financings came in ies. Excluding collaborations, the sector raised a total of $24.3 billion. above $6 billion—the second-best year over the past decade. Stock market performance Global biotech industry financing Although biotech indices were up ~16% last year, they underperformed The boost in partnership promises to US biotechs and follow-on financings other major indices. pushed industry funding to $61.3 billion, up 82% from 2008. 1,500 Swiss Market S&P 500 2009 36.9 10.0 5.1 2.2 6.0 0.9 1,400 NASDAQ Biotech Dow Jones 2008 20.0 3.2 5.3 3.1 1.9 0.1 1,300 NASDAQ BioCentury 100 2007 22.4 11.7 6.8 4.7 4.4 3.0 1,200 Partnering 2006 19.8 11.9 5.6 4.7 5.6 2.0 1,100 Year Debt and other Index 17.3 6.1 5.4 2.7 4.8 1.9 1,000 2005 Venture capital PIPEs 900 2004 10.9 8.8 5.3 2.9 3.3 2.6 Follow-ons 800 2003 8.9 9.1 4.0 2.2 3.9 0.5 IPOs 700 010203040506070 Amount raised ($ billions) 1/09 2/09 3/09 4/09 5/09 6/09 7/09 8/09 9/09 12/08 Month ending 10/09 11/09 12/09 Partnership figures are for deals involving a US company.
    [Show full text]
  • Unavoidably Unsafe Products and Strict Products Liability: What Liability Rule Should Be Applied to the Sellers of Pharmaceutical Products? Richard C
    Kentucky Law Journal Volume 78 | Issue 4 Article 3 1990 Unavoidably Unsafe Products and Strict Products Liability: What Liability Rule Should be Applied to the Sellers of Pharmaceutical Products? Richard C. Ausness University of Kentucky Follow this and additional works at: https://uknowledge.uky.edu/klj Part of the Consumer Protection Law Commons, and the Food and Drug Law Commons Right click to open a feedback form in a new tab to let us know how this document benefits you. Recommended Citation Ausness, Richard C. (1990) "Unavoidably Unsafe Products and Strict Products Liability: What Liability Rule Should be Applied to the Sellers of Pharmaceutical Products?," Kentucky Law Journal: Vol. 78 : Iss. 4 , Article 3. Available at: https://uknowledge.uky.edu/klj/vol78/iss4/3 This Article is brought to you for free and open access by the Law Journals at UKnowledge. It has been accepted for inclusion in Kentucky Law Journal by an authorized editor of UKnowledge. For more information, please contact [email protected]. Kentucky Law Journal Volume 78 1989-90 Number 4 Unavoidably Unsafe Products and Strict Products Liability: What Liability Rule Should be Applied to the Sellers of Pharmaceutical Products? BY RICHARD C. AusNEss* Table of Contents INTRODUCTION ....................................... 706 I. OVERVIEW ................................ 709 A. Strict Products Liability .............................. 709 B. Comment K and "Unavoidably Unsafe" Products ................................................... 712 II. COM[ENT K's LIABILITY REGm .......................... 719 A. Risks Associated with the Production Process. 720 B. Risks Arising from the Inherent Nature of a Product .................................................... 723 C. Risks Created by Conscious Design Choices .... 726 D. Scientifically Unknowable Risks ................... 731 E.
    [Show full text]
  • Transcept Pharmaceuticals, Inc
    Table of Contents SCHEDULE 14A (RULE 14A 101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by x Definitive Proxy Statement Rule 14a-6(e)(2)) ¨ Definitive Additional Materials ¨ Soliciting Material Pursuant to §240.14a-12 Transcept Pharmaceuticals, Inc. (Name of Registrant as Specified in its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): x No fee required. ¨ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities to which transaction applies: (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): (4) Proposed maximum aggregate value of transaction: (5) Total fee paid: ¨ Fee paid previously with preliminary materials. ¨ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. (1) Amount Previously Paid: (2) Form, Schedule or Registration Statement No.: (3) Filing Party: (4) Date Filed: Table of Contents NOTICE OF ANNUAL MEETING OF STOCKHOLDERS JUNE 23, 2011 To Our Stockholders: NOTICE IS HEREBY GIVEN that the Annual Meeting of Stockholders of Transcept Pharmaceuticals, Inc., a Delaware corporation, will be held on Thursday, June 23, 2011, at 8:30 a.m., local time, at our office located at 1003 West Cutting Blvd., Suite 110, Point Richmond, California 94804, for the following purposes: 1.
    [Show full text]
  • Manufacturers and Wholesalers Street
    Nevada AB128 Code of Conduct Compliant Companies Manufacturers and Wholesalers Street City ST Zip 10 Edison Street LLC 13 Edison Street LLC Abbott Diabetes Care Division Abbott Diagnostic Division Abbott Electrophysiology (including Kalila Medical 2- 2016)) Abbott Laboratories 100 Abbott Park Road, Dept. EC10, Bldg. APGA-2 Abbott Park IL 60064 Abbott Medical Optics Abbott Molecular Division Abbott Nutrition Products Division Abbott Vascular Division (includes Tendyne 9-2015) AbbVie, Inc. 1 N. Waukegan Road North Chicago IL 60064 Acadia Phamaceuticals 3611 Valley Centre Drive, Suite 300 San Diego CA 92130 Accelero Health Partners, LLC Acclarent, Inc. 1525-B O'Brien Dr. Menlo Park CA 94025 Accuri Cyometers, Inc. Ace Surgical Supply, Inc. 1034 Pearl St. Brockton MA 02301 Acorda Therapeutics, Inc. 420 Sawmill River Road Ardsley NY 10532 AcriVet, Inc. Actavis W.C. Holding, Inc. Morris Corporate Center III, 400 Interpace Parkway Parsippany NJ 07054 Actavis , Inc. Actelion Pharmaceuticals US, Inc. 5000 Shoreline Court, Suite 200 S. San Francisco CA 94080 Activis 400 Interpace parkway Parsippany NJ 07054 A-Dec, Inc. 2601 Crestview Dr. Newberg OR 97132 Advanced Respiratory, Inc. Advanced Sterilization Products 33 Technology Drive Irvine CA 92618 Advanced Vision Research, Inc., dba Akorn Consumer Health Aegerion Pharmaceuticals, Inc. 101 Main Street, Suite 1850 Cambridge MA 02142 Aesculap Implant Systems, Inc. Aesculap, Inc. 3773 Corporate Parkway Center Valley PA 18034 Aesthera Corporation Afaxys, Inc. PO Box 20158 Charleston SC 29413 AGMS, Inc. Akorn (New Jersey) Inc. Page 1 of 23 Pages 2/15/2017 Nevada AB128 Code of Conduct Compliant Companies Akorn AG (formerly Excelvision AG) Akorn Animal Health, Inc.
    [Show full text]
  • 05/01/02 Louisiana Medicaid Management
    APPENDIX C 05/01/02 LOUISIANA MEDICAID MANAGEMENT INFORMATION SYSTEM PAGE 1 DEPT OF HEALTH AND HOSPITALS - BUREAU OF HEALTH SERVICES FINANCING LOUISIANA MEDICAID PHARMACY BENEFITS MANAGEMENT UNIT ONLY THESE COMPANIES PRODUCTS ARE COVERED AND ONLY THOSE DOSAGE FORMS LISTED IN APPENDIX A. MEDICAID DRUG FEDERAL REBATE PARTICIPATING PHARMACEUTICAL COMPANIES LABELER PHARMACEUTICAL COMPANY EFFECTIVE END DATE CODE DATE 00002 ELI LILLY & CO 04/01/91 00003 E.R.SQUIBB & SONS,INC 04/01/91 00004 HOFFMAN-LA ROCHE,INC 04/01/91 00005 LEDERLE LABORATORIES AMERICAN CYANAMID 04/01/91 00006 MERCK SHARP & DOHME 04/01/91 00007 SMITHKLINE BEECHAM CORPORATION 04/01/91 00008 WYETH LABORATORIES 04/01/91 00009 THE UPJOHN COMPANY 04/01/91 00011 BECTON DICKINSON MICROBIOLOGY SYSTEMS 10/01/91 07/01/98 00013 ADRIA LABORATORIES DIV.OF ERBAMONT,INC 04/01/91 00014 G.D.SEARLE & CO 04/01/91 01/01/01 00015 MEAD JOHNSON & COMPANY 04/01/91 00016 KABI PHARMACIA 04/01/91 00021 REED & CARNRICK 10/01/96 01/01/97 00023 ALLERGAN,INC 04/01/91 00024 WINTHROP PHARMACEUTICALS 04/01/91 00025 G.D.SEARLE & CO 04/01/91 00026 MILES INC.,PHARMACEUTICAL DIVISION 04/01/91 00028 GEIGY PHARMACEUTICALS 04/01/91 00029 SMITHKLINE BEECHAM CORPORATION 04/01/91 00031 ROBINS,A.H. 04/01/91 00032 SOLVAY PHARMACEUTICALS 04/01/91 00033 SYNTEX 04/01/91 00034 THE PURDUE FREDERICK COMPANY 04/01/91 00037 CARTER-WALLACE,INC 04/01/91 00038 STUART PHARMACEUTICALS,ICI AMERICAS INC 04/01/91 07/01/01 00039 HOECHST-ROUSSEL PHARMACEUTICALS INC 04/01/91 00043 SANDOZ CONSUMER CORPORATION 04/01/91 00044 KNOLL PHARMACEUTICALS
    [Show full text]
  • Health Industry Business Communications Council
    Health Industry Business Communications Council Registered Labelers: Accredited Auto-ID Labeling Standards Argentina New MedTek Devices Pty Ltd Oxavita SRL Norseld Pty Ltd. Novadien Healthcare Pty Ltd The following companies Odontit S.A. (and/or their subsidiaries/ PAMPAMED S.R.L. Numedico Technologies Pty Ltd divisions) have applied PATEJIM SRL Opto Global Pty. Ltd. for a Labeler Identification Orthocell Limited Code (LIC) assignment with Austria Prolotus Technologies Pty Ltd HIBCC*. By doing so, they afreeze GmbH Red Milawa Pty Ltd dba Magic Mobility have demonstrated their AMI GmbH SDI Limited commitment to patient safety Bender Medsystems GmbH Signostics Ltd. and logistical efficiency for BHS Technologies GmbH Sirtex Medical Pty Ltd their customers, the industry Metasys Medizintechnik GmbH Smith & Nephew Surgical Pty. Ltd. and the public at large. PAA Laboratories GmbH Staminalift International Limited Safersonic Medizinprodukte Handels The Pipette Company Pty. Ltd. Any organization that is GmbH Thermo Electron Corporation interested in using the HIBC W & H Dentalwerk Burmoos GmbH Vush Pty Ltd uniform labeling system may apply for the assignment of VUSH STIMULATION Australia one or more LICs. William A Cook Australia Pty. Ltd. Adv. Surgical Design & Manufacture, Ltd. Last updated 9-21-2021 AirPhysio Pty Ltd Belgium Annalise-AI Pty Ltd 3M Europe Apollo Medical Imaging Technology Pty Advanced Medical Diagnostics SA/NV Ltd Analis SA/NV Benra Pty Ltd dba Gelflex Laboratories Baxter World Trade Bioclone Australia Pty. Ltd. Bio-Rad RSL Candelis, Inc. Bio-Rad Lab Inc Clinical Diag. Group DePuy Australia Pty. Ltd. Biosource Europe SA For more information, please dorsaVi Ltd Cilag NV contact the HIBCC office at: EC Certification Service GmbH Coris Bioconcept Fink Engineering Pty Ltd Fuji Hunt Photographic Chemicals NV 2525 E.
    [Show full text]
  • Overview of Ftc Antitrust Actions in Pharmaceutical Services and Products
    OVERVIEW OF FTC ANTITRUST ACTIONS IN PHARMACEUTICAL SERVICES AND PRODUCTS Health Care Division Bureau of Competition Federal Trade Commission Washington D.C. 20580 Markus H. Meier Assistant Director Bradley S. Albert Deputy Assistant Director Saralisa C. Brau Deputy Assistant Director September 2009 TABLE OF CONTENTS Page I. INTRODUCTION. ........................................................... 1 II. CONDUCT INVOLVING PHARMACEUTICAL SERVICES AND PRODUCTS. 3 A. Monopolization. ...................................................... 3 B. Agreements Not to Compete. ............................................ 8 C. Agreements on Price or Price-Related Terms. 14 D. Agreements to Obstruct Innovative Forms of Health Care Delivery or Financing. 20 E. Illegal Tying and Other Arrangements. .................................... 20 III. PHARMACEUTICAL MERGERS. ........................................... 20 A. Horizontal Mergers Between Direct Competitors. 20 B. Potential Competition Mergers. ......................................... 44 C. Innovation Market Mergers. ............................................ 47 D. Vertical Mergers...................................................... 49 IV. INDUSTRY GUIDANCE STATEMENTS...................................... 50 A. Advisory Opinions. ................................................... 50 B. Citizen Petition to the Food and Drug Administration. 51 V. AMICUS BRIEFS. ......................................................... 51 VI. INDICES. ............................................................
    [Show full text]
  • Chrysler Affiliate Rewards Program
    Chrysler Affiliate Rewards Program If you or your spouse work, or have retired from, one of the companies listed below, you may qualify for pricing as low as 1% Below Factory Invoice on a New FIAT! Check the list of companies below to see if your company qualifies.* A F O AAA-- State of Ohio Members Freightliner Of Tampa, Llc Ocala Freightliner ABB, Inc. Freightliner Of Toledo OCE'- North America Abbott Labs Freightliner Of Utah, Llc Ocean Freightliner, Ltd. Abbott, Nicholson, Quilter, Freightliner Trucks So. Florida Inc. O'connor Gmc, Inc. Esshaki & Youngblood PC Freightliner Twin Ports O'connor Truck Sales, Inc. Abercrombie & Fitch Freightmasters Ohio Machinery Company AboveNet Fresenius Medical dba Ohio CAT Abraxis Bioscience Inc. Fresno Truck Center Oklahoma City Freightliner Accor North America FRIENDLY MOTORCARS Oklahoma Farm Bureau Ace Hardware Corporation Fru-Con Construction Corporation Oklahoma Publishing Company, Action Western Star Fujisawa Healthcare Inc. The (OPUBCO) Actelion Pharmaceuticals US, Inc. Ftl And Ws Of Maine Old Dominion Freight Lines Action Couriers Ftl And Wst Of Tifton Oldcastle Inc. ADVANTAGE Health Solutions, Inc. Ftl Stl Wst Of Odessa Omaha Truck Center Inc Advance Publications Ftl Trucks Of South Florida Omni Care Health Plan Aearo Company Ftl, Stl And Wst Of Montgomery One Call Locators Aetna Ftl,Stl, and Western Star Of Dothan One Source Management Inc Affinia Group Fyda Freightliner Cincinnati Oracle Corporation Agar Truck Sales, Inc. Fyda Freightliner Columbus,Inc Organon Pharmaceuticals USA, Inc. AGCO Corporation Fyda Freightliner Pittsburgh Orlando Freightliner AGFA Corporation Fyda Freightliner Youngstown Orlando Freightliner South Aggreko, LLC ORRIN B HAYES, INC. Agricredit Acceptance LLC G Oscient Pharmaceuticals Agrilink Foods OSI Pharmaceuticals Gabrielli Ford Truck Sales AGSTAR Financial Services Otjen, Van Ert, Stangle, Lieb & Weir, S.C.
    [Show full text]
  • Manufacturers with Signed Rebate Agreements February 1 , 2011
    Wisconsin Medicaid Pharmacy Data Table Manufacturers with Signed Rebate Agreements February 1 , 2011 NEWLABELER NAME START END SC NEW LABELER NAME START END SC 00002 ELI LILLY AND COMPANY 1/1/1991 Y 00126 COLGATE ORAL PHARMACEUTICAL 1/1/1991 Y 00003 E R SQUIBB AND SONS INC. 1/1/1991 Y 00131 SCHWARZ PHARMA, INC. 1/1/1991 Y 00004 HOFFMANN LAROCHE INC 1/1/1991 00132 C B FLEET COMPANY INC. 1/1/1991 00005 LEDERLE LABORATORIES 1/1/1991 Y 00135 SMITHKLINE BEECHAM 1/1/1995 Y 00006 MERCK SHARP & DOHME 1/1/1991 Y 00143 WEST-WARD PHARMACEUTICAL C 1/1/1991 Y 00007 SMITHKLINE BEECHAM CORPORATI 1/1/1991 Y 00145 STIEFEL LABORATORIES INC. 1/1/1991 Y 00008 WYETH AYERST LABORATORIES 1/1/1991 Y 00149 PROCTER & GAMBLE PHARMACEU 1/1/1991 Y 00009 PHARMACIA AND UPJOHN 1/1/1991 Y 00168 E FOUGERA AND CO, DIV OF ALTAN 1/1/1991 Y 00013 PHARMACIA AND UPJOHN 1/1/1991 Y 00169 NOVO NORDISK PHARMACEUTICAL 1/1/1991 Y 00015 INVAMED, INC 1/1/1991 Y 00172 ZENITH LABORATORIES, INC 1/1/1991 Y 00023 ALLERGAN INC. 1/1/1991 Y 00173 GLAXOSMITHKLINE 1/1/1991 Y 00024 SANOFI SYNTHELABO 1/1/1991 Y 00178 MISSION PHARMACAL COMPANY 1/1/1991 Y 00025 PHARMACIA CORPORATION 1/1/1991 Y 00182 GOLDLINE LABORATORIES INC 1/1/1991 Y 00026 BAYER CORP PHARMACEUTICAL DI 1/1/1991 Y 00185 EON LABS MANUFACTURING, INC. 1/1/1991 Y 00028 NOVARTIS PHARMACEUTICALS 1/1/1991 Y 00186 ASTRAZENECA LP 1/1/1991 Y 00029 SMITHKLINE BEECHAM CORPORATI 1/1/1991 Y 00187 ICN PHARMACEUTICALS INC.
    [Show full text]
  • Sponsor List
    UVMClick Sponsor List Please contact SPA at [email protected] to update the Sponsor List last updated August 24, 2021 Is Publicly Sponsor Name Sponsor Type Is Foreign Vermont Sponsor Federal Agency Active Abbreviation Last Modified Date Sponsor ID Traded 106 Associates Industry no no Vermont Sponsor yes 106 Friday, January 29, 2021 12:35:03 PM 3385 3M Company Industry no yes yes 3M Company Friday, January 29, 2021 12:32:32 PM 2877 3M Pharmaceuticals Industry no yes yes 3M Pharmac Friday, January 29, 2021 12:39:23 PM 4188 835 Hinesburg Road, LLC Industry no no Vermont Sponsor yes 835 Friday, January 29, 2021 12:32:33 PM 3386 A Territory Resource Foundation no no yes A.T.R. Friday, January 29, 2021 12:34:11 PM 3805 A&C Realty LLC. Industry no no Vermont Sponsor yes A&C Realty Friday, January 29, 2021 12:40:28 PM 60 AAA Foundation for Traffic Safety Foundation no no yes AAAFDN Friday, January 29, 2021 12:36:49 PM 3806 AALV/New Farms for New Americans Foundation no no Vermont Sponsor yes AALV/New FFriday, January 29, 2021 12:32:25 PM 5154 Aarhus University Hospital Foundation yes no yes Aarhus Uni Friday, January 29, 2021 12:34:23 PM 5172 AARP Foundation no no yes AARP Friday, January 29, 2021 12:40:40 PM 2742 AARP Andrus Foundation Foundation no no yes AARPAF Friday, January 29, 2021 12:36:35 PM 3807 Abalone Bio Industry no no yes Abalone Bi Friday, January 29, 2021 12:37:14 PM 5178 Abbott Laboratories Fund Industry no yes yes Abbott Friday, January 29, 2021 12:32:46 PM 309 Abbott Nutrition Industry no yes yes Abbott Nut Friday, January 29, 2021 12:38:44 PM 5219 Abbott Vascular Industry no yes yes Abbott Vas Friday, January 29, 2021 12:35:57 PM 4192 AbbVie Inc.
    [Show full text]
  • CONCERT PHARMACEUTICALS, INC. (Exact Name of Registrant As Specified in Its Charter)
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Soliciting Material under §240.14a-12 CONCERT PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): x No fee required. ¨ Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (1) Title of each class of securities to which transaction applies: (2) Aggregate number of securities to which transaction applies: (3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): (4) Proposed maximum aggregate value of transaction: (5) Total fee paid: ¨ Fee paid previously with preliminary materials. ¨ Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. (1) Amount Previously Paid: (2) Form, Schedule or Registration Statement No.: (3) Filing Party: (4) Date Filed: 1 Concert Pharmaceuticals, Inc.
    [Show full text]
  • The Impact of Secondary Innovation on Firm Market Value in the Pharmaceutical Industry
    The Impact of Secondary Innovation on Firm Market Value in the Pharmaceutical Industry By: Maitri Punjabi Honors Thesis Economics Department The University of North Carolina at Chapel Hill March 2016 Approved: ______________________________ Dr. Jonathan Williams Punjabi 2 Abstract This paper analyzes the effect of the changing nature of innovation on pharmaceutical firm market value from the years 1987 to 2010 by using U.S. patent and claim data. Over the years, firms have started shifting focus from primary innovation to secondary innovation as new ideas and new compounds become more difficult to generate. In this study, we analyze the impact of this patent portfolio shift on the market capitalization of pharmaceutical firms. After using firm fixed effects and the instrumental variable approach, we find that there exists a strong positive relationship between secondary innovations and the market value of the firm– in fact, we find a stronger relationship than is observed between primary innovation and market value. When focusing on the different levels of innovation within the industry, we find that this relationship is stronger for less-innovative firms (those that have produced fewer patents) than it is for highly- innovative firms. We also find that this relationship is stronger for firms that spend less on research and development, complementing earlier findings that research productivity is declining over time. Punjabi 3 Acknowledgements I would primarily like to thank my adviser, Dr. Jonathan Williams, for his patience and constant support. Without his kind and helpful attitude, this project would have been a much more frustrating process. Through his knowledge of the industry, I have gained valuable insight and have learned a great deal about a unique and growing field.
    [Show full text]